Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(50%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

75%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Detailed Status

Completed2

Recruiting1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 21 (25.0%)

N/A3 (75.0%)

Trials by Status

recruiting125%

active_not_recruiting125%

completed250%

Recent Activity

2 active trials

Showing 4 of 4

recruitingphase_2

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

NCT06727773

active_not_recruitingnot_applicable

Clinical Trials (4)

Showing 4 of 4 trials

NCT06727773Phase 2

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

Recruiting

NCT07045324Not Applicable

Effect of Vagus Nerve Stimulation on Trapezius Trigger Point

Active Not Recruiting

NCT01467817Not Applicable

Obesity/Overweight in Persons With Early and Chronic Spinal Cord Injury (SCI)

Completed

NCT01572311Not Applicable

Dual Task Aerobic Exercise for Older Adults With Cognitive Impairment (HM2)

Completed

All 4 trials loaded

Drug Details

Intervention Type: OTHER
Total Trials: 4